Abstract
Despite hopes that antibiotic and vaccine therapies might one day lead to the complete eradication of infectious disease [1], new and emergent pathogens continue to pose a global threat to public health [2]. Even in the present day, infectious disease remains among the top ten causes of death in the United States for all age groups [3]. In part due to increased virulence of recent strains, but also due to a growing cohort of individuals susceptible to severe infection, the U.S. mortality rate caused by influenza has risen to roughly 36,000 per year, exceeding the current rate of HIV/AIDS related deaths in the country [4, 5]. While the victories over bubonic plague (Yersinia pestis), whooping cough (Bordetella pertussis), polio and smallpox (variola) are clearly significant, new diseases represented by human immunodeficiency virus (HIV), as well as the tragic reality of biological agents used as weapons of terrorism and mass destruction [6] — offer sobering evidence that the battle against infectious disease is far from over [7].
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
WHO (2002) Communicable Disease Surveillance and Response. World Health Organization Regional Office for Europe, Copenhagen
Noah D, Fidas G (2000) The Global Infectious Disease Threat and Its Implications for the United States. Gordon DF, Ed. National Intelligence Council, Washington, DC
Anderson RA (2001) Deaths: Leading Causes for 1999. National Vital Statistics Reports, Vol. 49, No. 11. CDC
Simonsen L, Fukuda K, Schonberger LB, Cox NJ (2000) J Infect Dis 181: 831
Ghendon Y (1992) World Health Stat Q 45: 306
Eldad A (2002) Harefuah 141: 21
Binder S, Levitt AM (2002) Emerging Infectious Diseases: A Strategy for the 21st Century. Centers for Disease Control
Meltzer MI, Cox NJ, Fukuda K (1999) Emerg Infect Dis 5: 659
Snacken R, Kendal AP, Haaheim LR, Wood JM (1999) Emerg Infect Dis 5: 195
Fong WK, Modrusan Z, McNevin JP, Marostenmaki J, Zin B, Bekkaoui F (2000) J Clin Microbiol 38: 2525
Brundtland GH (2000) World Health Organization Report on Infectious Diseases 2000
Uphoff H, Metzger C (2002) Dtsch Med Wochenschr 127: 1096
Goldmann DA (2001) Emerg Infect Dis 7: 249
Greenberg SB (2002) Curr Opin Pulm Med 8: 201
Lieberman D, Shvartzman P, Korsonsky I, Lieberman D (2001) Br J Gen Pract 51: 998
Franz DR, Zajtchuk R (2002) Dis Mon 48: 493
Gensheimer KF, Fukuda K, Brammer L, Cox N, Patriarca PA, Strikes RA (2002) Vaccine 20: S63
Nadder TS, Langley MR (2001) Clin Lab Sci 14: 252
Petersen K, McMillan W (2002) IVD Technology
Tang YW, Procop GW, Persing DH (1997) Clin Chem 43: 2021
McElhaney JE, Gravenstein S, Krause P, Hooton JW, Upshaw CM, Drinka P (1998) Clin Diagn Lab Immunol 5: 840
al-Nakib W, Dearden CJ, Tyrrell DA (1989) J Med Virol 29: 268
Mazzola LT, Fodor SP (1995) Biophys J 68: 1653
Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ (1999) Nat Genet 21: 20
Gabig M, Wegrzyn G (2001) Acta Biochim Pol 48: 615
Fodor SP, Read JL, Pirrung MC, Stryer L, Lu AT, Solas D (1991) Science 251: 767
Vignali DA (2000) J Immunol Methods 243: 243
Schaertl S, Meyer-Almes FJ (2001) Expert Rev Mol Diagn 1: 456
Pickering JW, Martins TB, Schroder MC, Hill HR (2002) Clin Diagn Lab Immunol 9: 872
Irmen KE, Kelleher JJ (2000) Clin Diagn Lab Immunol 7: 396
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Chuang, F.Y.S., Colston, B.W. (2004). Rapid, Multiplex Optical Biodetection for Point-of-Care Applications. In: Optical Sensors. Springer Series on Chemical Sensors and Biosensors, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09111-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-09111-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-07421-9
Online ISBN: 978-3-662-09111-1
eBook Packages: Springer Book Archive